Amy McGrath is a dynamic global strategic commercial leader currently serving as the Global Head of Rare Neurology & Metabolic Diseases at Sanofi. With a proven record of success in planning, launching, and driving the life cycle of products, Amy has extensive experience in chronic rare diseases and has led impactful global launches throughout their career. Previously, Amy held key positions at companies such as Shire, Talecris Biotherapeutics, and Clement Clarke International, where they developed innovative strategies and fostered partnerships to achieve significant market growth. Amy's expertise includes global commercial strategy, life cycle management, and collaborative cross-functional relationships.
This person is not in the org chart
This person is not in any teams
This person is not in any offices